Updated:
Heal Capital
The leading European HealthTech & AI venture capital fund. EUR 200m+ AUM, 27 portfolio companies, 8,000+ ventures evaluated. Investing EUR 1-5m from...
Heal Capital
The leading European HealthTech & AI venture capital fund. EUR 200m+ AUM, 27 portfolio companies, 8,000+ ventures evaluated. Investing EUR 1-5m from Pre-Seed to Series A, backed by 25+ health insurers, pharma, and institutional investors.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
Europe
Country
Germany
City
Berlin
Corporate office
Berlin, Germany
Sector focus
Frequently asked questions
What investment stages does Heal Capital target?
Heal Capital invests across seed, start-up, growth, and buyout stages. The firm's flexible mandate allows it to back healthcare companies at formation and later provide expansion capital or pursue control investments. This multi-stage approach is unusual among dedicated healthcare investors.
Which healthcare sub-sectors does Heal Capital focus on?
The firm concentrates on digital health platforms, tech-enabled healthcare services, and health IT infrastructure. Its thesis centers on companies that create clinical pathways which integrate with payer reimbursement systems, rather than pure consumer health apps or biotech.
What is Heal Capital's geographic focus?
Heal Capital invests primarily in Germany, Austria, and Switzerland, with selective exposure to Benelux and Nordic markets. The firm's focus on Europe's regulated reimbursement systems shapes this geographic concentration.
How does Heal Capital source its investments?
The firm sources through clinical networks and payer relationships rather than broad marketing. Heal Capital maintains a deliberately low public profile, consistent with a manager that relies on domain-specific relationships within European healthcare systems.
Is Heal Capital a venture capital firm or a private equity firm?
Heal Capital operates as both. The firm makes venture-stage investments in seed and start-up companies while also pursuing growth equity and buyout transactions. This hybrid structure allows it to support healthcare businesses across their entire lifecycle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: